EORTC


Also found in: Acronyms, Wikipedia.

EORTC

Abbreviation for:
European Organisation for the Research and Treatment of Cancer
References in periodicals archive ?
Chairman and CEO of Ignyta said, Since we first initiated dialog with the leadership of the EORTC SPECTA initiative a year-and-a-half ago, we have shared their vision to conduct efficient biomarker-driven clinical trials of innovative new cancer medicines.
Working with the EORTC is a key step in our strategy to establish a network of relationships within the clinical oncology community to support the conduct of the ICT-107 Phase 3 trial," said Andrew Gengos, ImmunoCellular's Chief Executive Officer.
A prospective, randomized EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
The aim of the EORTC is to facilitate the passage of experimental discoveries into state-of-the-art treatments by keeping to a minimum the time lapse between the discovery of new anti-cancer agents and the implementation of their therapeutic benefit for patients with cancer.
Keywords: Cancer; Mistletoe; Quality of life; Qualitative research; Interviews; EORTC QLQ-C30
EORTC has the mission to develop, conduct, coordinate and stimulate laboratory and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patients' quality of life.
We are very committed to making our partnership with the EORTC Charitable Trust a huge success and proud to be involved in this worthy cause.
The EORTC guidelines were developed by a multi-disciplinary team of experts in the fields of oncology and haematology who conducted a systematic review of the literature published between 1996 - 2003.
Conclusive results of a randomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group.
Health-related QoL was measured using the EORTC QLQ-C30 questionnaire, which evaluated global health status/QoL (overall well-being) in addition to physical, cognitive, role, social and emotional functioning.
The EORTC randomized patients with advanced melanoma to drug combinations that did not employ Genasense and showed no between-treatment differences.